Terms: = Head and neck cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
976 results:
1. Tripartite Motif-containing Protein 11 Silencing Inhibits Proliferation and Glycolysis and Promotes Apoptosis of Esophageal Squamous Cell Carcinoma Cells by Inactivating Signal Transduction and Activation of Transcription Factor 3/c-Myc Signaling.
Xuan T
; 2024 Jan; 67(1):37-46. PubMed ID: 38780271
[TBL] [Abstract] [Full Text] [Related]
2. cancer-associated fibroblast-derived periostin promotes papillary thyroid tumor growth through integrin-FAK-stat3 signaling.
Jin X; Deng Q; Ye S; Liu S; Fu Y; Liu Y; Wu G; Ouyang G; Wu T
Theranostics; 2024; 14(7):3014-3028. PubMed ID: 38773979
[No Abstract] [Full Text] [Related]
3. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/stat3 axis.
Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A
Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775
[TBL] [Abstract] [Full Text] [Related]
4. Chaga mushroom extract suppresses oral cancer cell growth via inhibition of energy metabolism.
Yeo D; Yun YG; Shin SJ; Dashnyam K; Khurelbaatar A; Lee JH; Kim HW
Sci Rep; 2024 May; 14(1):10616. PubMed ID: 38720012
[TBL] [Abstract] [Full Text] [Related]
5. PLAU promotes cell proliferation and migration of head and neck cancer via stat3 signaling pathway.
Cui X; Sun H; Liu X; Bai Y; Bai Y; Cui Y; Wang B; Zhang S; Li X
Exp Cell Res; 2024 May; 438(2):114056. PubMed ID: 38663475
[TBL] [Abstract] [Full Text] [Related]
6. Enhancing cancer therapy: The role of drug delivery systems in stat3 inhibitor efficacy and safety.
Wang KN; Zhou K; Zhong NN; Cao LM; Li ZZ; Xiao Y; Wang GR; Huo FY; Zhou JJ; Liu B; Bu LL
Life Sci; 2024 Jun; 346():122635. PubMed ID: 38615745
[TBL] [Abstract] [Full Text] [Related]
7. Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Wang Z; Zong H; Liu W; Lin W; Sun A; Ding Z; Chen X; Wan X; Liu Y; Hu Z; Zhang H; Li H; Liu Y; Li D; Zhang S; Zha X
J Exp Clin Cancer Res; 2024 Apr; 43(1):112. PubMed ID: 38610018
[TBL] [Abstract] [Full Text] [Related]
8. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
Cheng Y; Song Z; Fang X; Tang Z
Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608
[TBL] [Abstract] [Full Text] [Related]
9. [High LINC00626 expression promotes esophagogastric junction adenocarcinoma metastasis: the mediating role of the JAK1/stat3/KHSRP axis].
Zhang F; Fan L; Kang X; Wei H; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):541-552. PubMed ID: 38597446
[TBL] [Abstract] [Full Text] [Related]
10. Blocking senescence and tolerogenic function of dendritic cells induced by γδ Treg cells enhances tumor-specific immunity for cancer immunotherapy.
Si F; Liu X; Tao Y; Zhang Y; Ma F; Hsueh EC; Puram SV; Peng G
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580332
[TBL] [Abstract] [Full Text] [Related]
11. PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and stat3/HSP60 signaling pathways to treat nasopharyngeal carcinoma.
Cao J; Zeng K; Chen Q; Yang T; Lu F; Lin C; Zhan J; Ma W; Zhou T; Huang Y; Luo F; Zhao H
Cell Death Dis; 2024 Mar; 15(3):237. PubMed ID: 38555280
[TBL] [Abstract] [Full Text] [Related]
12. Unlocking the Therapeutic Potential of LncRNA
Liu FL; Zhang ZC; Zhou SL; Liu XL; Xu W
Discov Med; 2024 Mar; 36(182):546-558. PubMed ID: 38531795
[TBL] [Abstract] [Full Text] [Related]
13. Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via stat3 activation.
Lu Z; Liu J; Wan Q; Wu Y; Wu W; Chen Y
Mol Biol Rep; 2024 Mar; 51(1):436. PubMed ID: 38520551
[TBL] [Abstract] [Full Text] [Related]
14. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma.
Duan Y; Zhou M; Ye B; Yue K; Qiao F; Wang Y; Lai Q; Wu Y; Cao J; Wu Y; Wang X; Jing C
Cell Death Dis; 2024 Mar; 15(3):215. PubMed ID: 38485986
[TBL] [Abstract] [Full Text] [Related]
16. Tumor Necrosis Factor α-Induced Protein 8-Like 1 Binds to Protein Arginine Methyltransferase 1 to Suppress the Methylation of Signal Transducer and Activator of Transcription 3 and Cell Growth in Oral Squamous Cell Carcinoma.
Liu B; Si W; Wei B; Zhang X; Chen P
Am J Pathol; 2024 Jun; 194(6):1126-1136. PubMed ID: 38432512
[TBL] [Abstract] [Full Text] [Related]
17. Sciellin promotes the development and progression of thyroid cancer through the JAK2/stat3 signaling pathway.
Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
[TBL] [Abstract] [Full Text] [Related]
18. Exploring miR-155-5p and miR-1246 as Diagnostic and Prognostic Markers in Oral Squamous cell carcinoma.
Maheswari R; Urs AB; Kumar P; Koner BC; Guru SA; Rawat G
Mol Biol Rep; 2024 Feb; 51(1):341. PubMed ID: 38400867
[TBL] [Abstract] [Full Text] [Related]
19. Ascorbic acid induces ferroptosis via stat3/GPX4 signaling in oropharyngeal cancer.
Wu K; Liu L; Wu Z; Huang Q; Zhou L; Xie R; Wang M
Free Radic Res; 2024 Feb; 58(2):117-129. PubMed ID: 38385781
[TBL] [Abstract] [Full Text] [Related]
20. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Besse B; Pons-Tostivint E; Park K; Hartl S; Forde PM; Hochmair MJ; Awad MM; Thomas M; Goss G; Wheatley-Price P; Shepherd FA; Florescu M; Cheema P; Chu QSC; Kim SW; Morgensztern D; Johnson ML; Cousin S; Kim DW; Moskovitz MT; Vicente D; Aronson B; Hobson R; Ambrose HJ; Khosla S; Reddy A; Russell DL; Keddar MR; Conway JP; Barrett JC; Dean E; Kumar R; Dressman M; Jewsbury PJ; Iyer S; Barry ST; Cosaert J; Heymach JV
Nat Med; 2024 Mar; 30(3):716-729. PubMed ID: 38351187
[TBL] [Abstract] [Full Text] [Related]
[Next]
